During the five-year period January 2001 to December 2005, the Drug Analysis and
Research Unit received and analyzed 394 drug samples. Samples were received from
regulatory authorities, local industry, non-governmental organizations, hospitals
and private practitioners. The samples analyzed constituted 37.8 % locally
manufactured and 62.2 % imported products. In contrast to previous years when
failure rates of over 20 % were recorded, the overall rate of failure to comply with
compendial quality specifications was 6.1 %, comprising of 8.7 % locally
manufactured and 4.5 % imported drugs.